• Profile
Close

Early stage lung cancer survival after wedge resection and stereotactic body radiation

Journal of Thoracic Disease Oct 31, 2018

Taioli E, et al. - In patients with stage I non-small cell lung cancer (NSCLC), the efficacy of wedge resection vs stereotactic body radiation therapy (SBRT) was compared in terms of 5-year overall survival (OS), via a meta-analysis. Researchers used the National Library of Medicine and National Institutes of Health PubMed database and the reference lists of reviewed articles to identify original research articles published between 1995 and 2017. Data were processed and analyzed in R (version 3.4.2). They calculated a summary estimate that accounted for the sample size of each study. According to findings, SBRT was earmarked for treating patients considered medically inoperable. However, in medically operable patients who preferred a less invasive treatment, SBRT could be an alternative to surgery. A higher 5-year OS was seen following wedge resection in two articles directly comparing stage I NSCLC patients treated with wedge resection to patients treated with SBRT.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay